As concern grows for the escalating prices of prescription drugs, a novel approach to lower the price of drugs to treat hepatitis C in Louisiana holds promise, a policy expert says.
L’expertise universitaire, l’exigence journalistique
Articles sur Sovaldi
Ensemble des articles
Developing brand new treatments and cures isn’t the only way to achieve a major reduction in cancer deaths worldwide.
It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…
Les contributeurs les plus fréquents
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Health Services Researcher, The University of Melbourne
-
Professor of Public Policy, University of Southern California
-
Richard Doll Professor of Epidemiology and Medicine, University of Oxford
